143 related articles for article (PubMed ID: 15052231)
1. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature.
Filosso PL; Actis Dato GM; Ruffini E; Bretti S; Ozzello F; Mancuso M
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1215-9. PubMed ID: 15052231
[No Abstract] [Full Text] [Related]
2. Large cell neuroendocrine carcinoma of the lung: what we have to do.
Filosso PL
J Thorac Cardiovasc Surg; 2003 May; 125(5):1182-3; author reply 1183-4. PubMed ID: 12771909
[No Abstract] [Full Text] [Related]
3. Neuroendocrine carcinoma of the thymus gland with sternal invasion.
Dutta R; Kumar A; Jindal T; Mathur SR
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):694-6. PubMed ID: 19258349
[TBL] [Abstract][Full Text] [Related]
4. Solitary atrial myocardial metastasis revealing ileal neuroendocrine carcinoma.
Meurice J; Boulé S; Deswarte G; Brigadeau F; Modine T
Cardiovasc Pathol; 2012; 21(4):355-7. PubMed ID: 22138424
[TBL] [Abstract][Full Text] [Related]
5. Thymic neuroendocrine carcinoma presenting as cushing's syndrome: treatment with octreotide combined with surgery and radiotherapy.
Asicioglu E; Gonenli G; Kahveci A; Yildizeli B; Deyneli O; Yavuz D; Yuksel M; Akalin S
Onkologie; 2011; 34(1-2):46-9. PubMed ID: 21346385
[No Abstract] [Full Text] [Related]
6. [Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide].
Rischke HC; Staib-Sebler E; Mose S; Adams SW; Herrmann G; Böttcher HD; Lorenz M
Dtsch Med Wochenschr; 1999 Feb; 124(7):182-6. PubMed ID: 10093577
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment of neuroendocrine tumors of the thymus.
Dosios T; Nikou GC; Toubanakis C; Filippides T; Papachristou D
Thorac Cardiovasc Surg; 2005 Oct; 53(5):305-9. PubMed ID: 16208618
[TBL] [Abstract][Full Text] [Related]
8. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
[No Abstract] [Full Text] [Related]
9. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
10. [Thymic carcinoma; report of a case].
Muro M; Kubo S; Yoshioka T; Idani H; Ishikawa T; Ishii T; Asami S; Kurose Y; Hirata M; Yamashita T; Kin H
Kyobu Geka; 2009 Feb; 62(2):169-71. PubMed ID: 19202942
[TBL] [Abstract][Full Text] [Related]
11. [Merkel cell tumor: a case report and literature review].
Marullo M; Cancellieri A; Lemma G; Ballarino F; Lemma F
G Chir; 2004; 25(11-12):395-7. PubMed ID: 15803813
[TBL] [Abstract][Full Text] [Related]
12. ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1.
Yano M; Fukai I; Kobayashi Y; Mizuno K; Konishi A; Haneda H; Suzuki E; Endo K; Fujii Y
Ann Thorac Surg; 2006 Jan; 81(1):366-8. PubMed ID: 16368411
[TBL] [Abstract][Full Text] [Related]
13. Mucoepidermoid carcinoma of the thymus treated by multimodality therapy: a case report.
Noda T; Higashiyama M; Oda K; Higaki N; Takami K; Okami J; Kodama K; Kuriyama K; Tsukamoto Y; Kobayashi H
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):273-8. PubMed ID: 16977299
[TBL] [Abstract][Full Text] [Related]
14. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide.
Filosso PL; Ruffini E; Oliaro A; Rena O; Casadio C; Mancuso M; Turello D; Cristofori RC; Maggi G
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):819-24. PubMed ID: 15821649
[TBL] [Abstract][Full Text] [Related]
15. Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
Pregun I; Gergics P; Dabasi G; Igaz P; Racz K; Tulassay Z
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):476-7. PubMed ID: 19382304
[No Abstract] [Full Text] [Related]
16. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
Dakin GF; Warner RR; Pomp A; Salky B; Inabnet WB
J Surg Oncol; 2006 Apr; 93(5):368-72. PubMed ID: 16550587
[TBL] [Abstract][Full Text] [Related]
17. Cytology of metastatic thymic well-differentiated neuroendocrine carcinoma (thymic carcinoid) in pleural fluid: report of a case.
Cameron SE; Alsharif M; McKeon D; Pambuccian SE
Diagn Cytopathol; 2008 May; 36(5):333-7. PubMed ID: 18418883
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid tumour.
McStay MK; Caplin ME
Minerva Med; 2002 Oct; 93(5):389-401. PubMed ID: 12410171
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
Okabe N; Inoue T; Watanabe Y; Muto S; Hasegawa T; Ohsugi J; Higuchi M; Shio Y; Suzuki H
Gan To Kagaku Ryoho; 2014 Jul; 41(7):879-83. PubMed ID: 25131876
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A as a determinant of midgut carcinoid tumour volume.
Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O
Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
